RhythmAnalytics vs Aorta-CAD
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of cardiac arrhythmias from single-lead ECG data. This tool is ideal for healthcare professionals and integrators seeking clinical decision support for a wide range of arrhythmias, compatible with various FDA-cleared ECG devices.
View RhythmAnalytics →Choose Aorta-CAD if…
Choose Aorta-CAD if you need AI assistance in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays. This cloud-based software seamlessly integrates into existing X-ray reading workflows, providing annotations to help radiologists and PCPs improve the accuracy of their diagnostic imaging interpretations.
View Aorta-CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | Aorta-CAD |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Cloud-based API | Cloud-based |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Aorta-CADTool B (Aorta-CAD) offers seamless integration into existing X-ray reading workflows with a toggleable overlay for annotations, indicating a direct and intuitive user experience for physicians within their established PACS environment. Tool A (RhythmAnalytics) is primarily a cloud-based API for integration, making its direct clinical end-user usability more dependent on the integrator's implementation, although it supports patient-facing apps for device setup and monitoring.
Clinical Value
Aorta-CADBoth tools demonstrate strong clinical value with FDA clearance and supporting studies. Tool B (Aorta-CAD) provides specific, quantified clinical study results, showing a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta, with 96% of physicians demonstrating improvement when assisted by the device. Tool A (RhythmAnalytics) also shows strong performance with high sensitivity and specificity, even outperforming cardiologists in arrhythmia detection, but Tool B's direct impact on reducing diagnostic misses is a highly tangible clinical benefit.
Pricing & Value
TieBoth Tool A (RhythmAnalytics) and Tool B (Aorta-CAD) have opaque pricing models, requiring direct contact with the vendor for information. Without transparent pricing details or publicly available cost structures, it is impossible to conduct a head-to-head comparison of their value propositions.
Enterprise Readiness
Aorta-CADTool B (Aorta-CAD) explicitly states it is HIPAA compliant, FDA cleared, and has a Business Associate Agreement (BAA) in place, which is crucial for healthcare enterprise adoption. It also emphasizes seamless integration into existing X-ray workflows without requiring new PACS technology or costly re-training. While Tool A (RhythmAnalytics) is HIPAA compliant and FDA cleared, its BAA status is unspecified in the provided data, giving Tool B a slight edge in documented enterprise readiness.
Innovation
RhythmAnalyticsBoth tools leverage advanced deep learning. Tool A (RhythmAnalytics) demonstrates significant innovation by using a novel deep learning architecture to achieve cardiologist-level arrhythmia detection and classification, outperforming both human cardiologists and other AI systems in clinical studies. Its ability to interpret over 30 types of cardiac arrhythmias from diverse single-lead ECG data sources, including wearables, highlights its advanced AI capabilities and broad application in remote monitoring.
Support & Docs
Aorta-CADTool B (Aorta-CAD) provides comprehensive details about its program support, including 24/7 availability for equipment, IT, and integration issues, along with extensive assistance for installation, EMR integration, and staff training. Tool A (RhythmAnalytics), while part of a larger platform with clinical escalation management, has less specific information available regarding support and documentation for its API product in the search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | Aorta-CAD |
|---|---|---|
| Name | RhythmAnalytics | Aorta-CAD |
| Company | Biofourmis Singapore Pte. | Imagen Technologies |
| Primary Application/Focus | Automated interpretation of cardiac arrhythmias from single-lead ECG data, clinical decision support. | Detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, assisting physicians in interpreting chest X-rays. |
| Specific Detections/Interpretations | Over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats), beat-by-beat morphology computation, QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, rhythm analysis. | Radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia. |
| Integration Method | Cloud-based API for integration | Seamlessly integrates into existing X-ray reading workflows, creates annotations via an overlay. |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Internal Medicine, Radiology |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and Aorta-CAD.